Morgan Stanley Stock News

Morgan Stanley increased its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) by 218.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 271,673 shares of the biotechnology companys stock after purchasing an additional 186,329 shares during the quarter. Morgan Stanley owned []

Morgan Stanley reduced its stake in Sterling Bancorp (NYSE:STL) by 23.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 247,527 shares of the financial services providers stock after selling 77,109 shares during the quarter. Morgan Stanleys holdings in Sterling Bancorp were worth $6,135,000 at []

Morgan Stanley increased its stake in ADC Therapeutics SA (NYSE:ADCT) by 22.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 249,527 shares of the companys stock after purchasing an additional 45,300 shares during the quarter. Morgan Stanley owned approximately 0.36% of ADC []

Morgan Stanley increased its holdings in shares of Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) by 133.9% in the 2nd quarter, HoldingsChannel reports. The firm owned 270,874 shares of the companys stock after acquiring an additional 155,085 shares during the quarter. Morgan Stanleys holdings in Petco Health and Wellness were worth $6,070,000 as of its []

Morgan Stanley raised its stake in shares of Everi Holdings Inc. (NYSE:EVRI) by 29.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 245,500 shares of the credit services providers stock after buying an additional 55,640 shares during the period. Morgan []

Donaldson (NYSE:DCI) had its price target reduced by Robert W. Baird from $73.00 to $70.00 in a research note released on Thursday, The Fly reports. Robert W. Baird currently has an outperform rating on the industrial products companys stock. Separately, Morgan Stanley dropped their price objective on shares of Donaldson from $75.00 to $73.00 and []

TotalEnergies (NYSE:TTE)s stock had its buy rating reaffirmed by stock analysts at Kepler Capital Markets in a report issued on Friday, AnalystRatings.com reports. Several other brokerages also recently weighed in on TTE. JPMorgan Chase & Co. reissued a neutral rating on shares of TotalEnergies in a research note on Monday, November 29th. Morgan Stanley reaffirmed []

Ares Management (NYSE:ARES)s stock had its hold rating reiterated by Morgan Stanley in a research report issued to clients and investors on Friday, Analyst Price Targets reports. They presently have a $92.00 price target on the asset managers stock. Morgan Stanleys price target points to a potential upside of 15.16% from the stocks previous close. []

Goldman Senior Executives Are Searching For Ways To Quietly Boost Their Own Pay What''s good for the gander is good for the geese, right? It seems that way at Goldman Sachs. No sooner do we write about how Goldman Sachs is looking to implement additional paid leave for its rank-and-file employees in order to keep morale up than it was revealed that the company''s bosses are also looking at ways of improving their own yacht collection quality of life. In fact, CEO David Solomon and the top brass at the bank are reportedly "searching for ways to juice their own eight-digit pay packages," Bloomberg reported this week. Solomon''s total stake in the company, including unvested stock, is worth about $180 million already the report says. He made $27.5 million his first full year as CEO and the same the next year, in 2020. Solomon also was given a $50 million bonus plan to be split with another employee in October of this year. That off-cycle bonus came as a result of Goldman''s skyrocketing stock price, which is up about 80% since Solomon took over as CEO.

Argus Investors Counsel Inc. reduced its stake in Morgan Stanley (NYSE:MS) by 54.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,520 shares of the financial services providers stock after selling 27,180 shares during the period. Morgan Stanley accounts for 1.4% []

GPS Wealth Strategies Group LLC trimmed its holdings in Morgan Stanley (NYSE:MS) by 5.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 16,290 shares of the financial services providers stock after selling 1,026 shares during the quarter. GPS Wealth Strategies Group LLCs holdings in Morgan Stanley were worth $1,585,000 at the end of the []

E&G Advisors LP purchased a new stake in shares of Morgan Stanley (NYSE:MS) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 8,301 shares of the financial services providers stock, valued at approximately $808,000. A number of other hedge funds and other institutional investors []

Enfusion (NYSE:ENFN) had its price target lowered by Morgan Stanley from $24.00 to $22.00 in a research note published on Friday morning, Price Targets.com reports. The firm currently has an equal weight rating on the stock. ENFN has been the subject of a number of other research reports. Bank of America started coverage on Enfusion []

Morgan Stanley started coverage on shares of Crane (NYSE:CR) in a research report sent to investors on Friday, Analyst Ratings Network reports. The firm issued an equal weight rating and a $111.00 price target on the conglomerates stock. Several other research analysts have also weighed in on CR. Zacks Investment Research upgraded shares of Crane []

Morgan Stanley initiated coverage on shares of CAE (NYSE:CAE) (TSE:CAE) in a report published on Friday, The Fly reports. The firm issued an equal weight rating and a $37.00 price target on the aerospace companys stock. Several other research analysts have also recently commented on the stock. Desjardins lowered their price target on shares of []